tACS
7
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
1 terminated out of 7 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome
Speed of Processing (SoP) Training Plus α-tACS
Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression
An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
Transcranial Direct/ Alternating Current Stimulation for Parkinson's Disease Treatment
Transcranial Alternating Current Stimulation (TACS) for Sleep Disturbances in Neurocognitive Disorders Due to Alzheimer's Disease
tACS Improves Memory in Elders With Subjective Memory Complaints